Medical News

---

• Cognitive deficits do not indicate oncoming manic episode
• Cognition unaffected by substance abuse in first-episode schizophrenia
• Cognitive deficits do not indicate oncoming manic episode
• Cognition unaffected by substance abuse in first-episode schizophrenia
• Pitfall in Friedewald equation for ‘bad’ cholesterol
• Pitfall in Friedewald equation for ‘bad’ cholesterol
• Potential interstitial lung disease markers identified
• Modified prediction model may improve lung cancer detection
• Erlotinib may improve life quality in advanced NSCLC
• New model estimates final menstrual period in menopause
• Hsp90 inhibitor shows NSCLC promise
• Surveillance imaging ‘unjustified’ in rituximab-treated lymphoma
• T-cell therapy holds promise for ALL children
• Hsp90 inhibitor shows NSCLC promise
• Diet linked to severe asthma
• Over half of lumbar spine MRIs inappropriate, of uncertain value

Cognitive deficits do not indicate oncoming manic episode Posted: 02 Apr 2013 05:00 PM PDT Neurocognitive deficits among those who are at ultra high risk for psychosis do not significantly differ between those who transition to bipolar disorder and those who do not transition to bipolar disorder or psychosis, a study finds.

Cognition unaffected by substance abuse in first-episode schizophrenia Posted: 02 Apr 2013 05:00 PM PDT Substance abuse does not seem to affect cognitive functioning in patients with their first episode of schizophrenia, suggest findings from a post-hoc analysis of the European First Episode Schizophrenia Trial.

Cognitive deficits do not indicate oncoming manic episode Posted: 02 Apr 2013 05:00 PM PDT Neurocognitive deficits among those who are at ultra high risk for psychosis do not significantly differ between those who transition to bipolar disorder and those who do not transition to bipolar disorder or psychosis, a study finds.

Cognition unaffected by substance abuse in first-episode schizophrenia Posted: 02 Apr 2013 05:00 PM PDT Substance abuse does not seem to affect cognitive functioning in patients with their first episode of schizophrenia, suggest findings from a post-hoc analysis of the European First Episode Schizophrenia Trial.

Pitfall in Friedewald equation for ‘bad’ cholesterol Posted: 01 Apr 2013 05:00 PM PDT Using the Friedewald equation to estimate levels of low-density lipoprotein cholesterol is the least accurate in patients for whom accuracy is most critical, shows the largest analysis to date.

Pitfall in Friedewald equation for ‘bad’ cholesterol Posted: 01 Apr 2013 05:00 PM PDT Using the Friedewald equation to estimate levels of low-density lipoprotein cholesterol is the least accurate in patients for whom accuracy is most critical, shows the largest analysis to date.

Potential interstitial lung disease markers identified Posted: 01 Apr 2013 05:00 PM PDT Study findings suggest that three proteins may be associated with interstitial lung disease development.

Modified prediction model may improve lung cancer detection Posted: 01 Apr 2013 05:00 PM PDT A modified lung cancer prediction model that includes risk factors identified in the National Lung Screening Trial may boost the accuracy with which 6-year lung cancer risk can be predicted, researchers report.

Erlotinib may improve life quality in advanced NSCLC Posted: 01 Apr 2013 05:00 PM PDT Treating advanced epidermal growth factor receptor-mutation-positive non-small-cell lung cancer with erlotinib appears to improve quality of life compared with standard first-line chemotherapy, study results indicate.

New model estimates final menstrual period in menopause Posted: 01 Apr 2013 05:00 PM PDT US researchers have developed a model for estimating the timing of the final menstrual period, giving reassurance and the possibility of clinical guidance on preventative interventions for at-risk menopausal women.

Hsp90 inhibitor shows NSCLC promise Posted: 01 Apr 2013 05:00 PM PDT Treatment with a heatshock protein 90 inhibitor may induce loss of EML4–AKL expression in non-small cell lung cancer cells, preliminary results suggest.

Surveillance imaging ‘unjustified’ in rituximab-treated lymphoma Posted: 01 Apr 2013 05:00 PM PDT Surveillance fluorodeoxyglucose positron emission tomography delivers a high false-positive rate and has low specificity during follow up in diffuse large cell lymphoma patients treated with rituximab, a study shows.

T-cell therapy holds promise for ALL children Posted: 01 Apr 2013 05:00 PM PDT Two children with relapsed and chemotherapy-refractory pre-B-cell acute lymphoblastic leukemia achieved complete remission after treatment with modified T cells, show study findings published in TheNew England Journal of Medicine.

Hsp90 inhibitor shows NSCLC promise Posted: 01 Apr 2013 05:00 PM PDT Treatment with a heatshock protein 90 inhibitor may induce loss of EML4–AKL expression in non-small cell lung cancer cells, preliminary results suggest.

Diet linked to severe asthma Posted: 01 Apr 2013 05:00 PM PDT Individuals with severe persistent asthma consume more fat and less fiber than healthy individuals, and this is associated with reduced lung function and increased airway inflammation, show study results.

Over half of lumbar spine MRIs inappropriate, of uncertain value Posted: 01 Apr 2013 05:00 PM PDT Magnetic resonance imaging is vastly overused in patients with lower back pain, a Canadian study suggests.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610